COVID-19 vaccination may increase risk for urinary tract symptoms
Aug 01, 2024
A higher proportion of those who received a single dose versus three doses had to urinate five or more times in the night.
EPA designates two ‘forever chemicals’ as hazardous
Apr 22, 2024
Two common PFAS “forever chemicals” have been deemed hazardous substances by the Environmental Protection Agency.
Fragments of bird flu virus found in 1 in 5 milk samples
Apr 26, 2024
Bits of bird flu virus have been discovered in roughly 20% of retail milk samples tested in a national survey, the US Food and Drug Administration said Thursday.
CDC reports third dairy worker infected with bird flu, risk to public remains ‘low’
May 30, 2024
Amid an ongoing outbreak of bird flu in dairy cows, there’s been a third case of H5N1 avian flu confirmed in a dairy worker, US health officials reported Thursday.
US to strengthen protections for air travelers with wheelchairs
Feb 29, 2024
An estimated 5.5 million Americans use a wheelchair, the US Department of Transportation (DOT) said. In 2023, 11,527 wheelchairs and scooters were lost, delayed, damaged or stolen by airlines.
Type 2 diabetes prevalence rose in the United States from 2012 to 2022
Aug 02, 2024
The prevalence was highest among non-Hispanic Black people (15.8%) and individuals aged 65 years and older (23.86%).
PREVENT equations reclassify half of US adults to lower ASCVD risk
Aug 02, 2024
A considerable decrease was estimated in US adults receiving or recommended for preventive treatment with statins and antihypertensives.
Most traditional cardiovascular risk factors not linked to migraine
Jul 31, 2024
Current smoking, diabetes mellitus and higher fasting glucose level all were linked to lower prevalence of migraine in women.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Expanded use of Xolair to treat food allergies approved by the FDA
Feb 17, 2024
Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen.